‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old. A new book aims to educated young ...
The subsequent treatment involved intensive procedures, including five rounds of chemotherapy, external beam radiation, and ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...
Caregivers must respect the autonomy of adult patients, balancing support with allowing them to lead their own cancer journey ...
CURE had the privilege of attending the Hairy Cell Leukemia Foundation 2025 Conference in Bologna, Italy, where medical experts gathered to discuss advances in research, treatment ...
While October promotes awareness through campaigns, ribbons and fundraising, survivors report a more complex reality. Breast cancer survivor Maureen Green described the month as a reminder of the ...
PhD in clinical psychology. She is a senior psychologist, director of Interprofessional Education and director of the Young Adult Program (YAP) in the Department of Supportive Oncology at Dana-Farber ...
“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...
CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.
CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback